Acute closed soft tissue injury of the ankle and foot
Conditions
Interventions
Experimental group:Conventional treatment combined with Yunnan Baiyao aerosol
Control group:Conventional treatment
Sponsors
Shanghai Sixth People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 65 years; 2. Meet the Western medicine diagnostic criteria for acute closed soft tissue injury, and the injury is unilateral on the foot or ankle; 3. Disease duration <= 48 hours at screening; 4. Agree to participate in this clinical trial and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who have fractures induced by pathological factors; 2. Patients who require plaster fixation, compression dressing, surgical treatment, etc., and cannot use the investigational drug; 3. Patients with blisters, ulcers, or suppuration on the injured skin; 4. Patients whose current foot and ankle pain and swelling are caused by other diseases, such as an acute episode of gout; 5. Patients with severe primary diseases and dysfunctions of the heart, brain, liver, kidney, hematopoietic system, endocrine system, etc.; 6. Patients known to be allergic to Yunnan Baiyao aerosol, alcohol, or similar substances, or with an allergic constitution (allergic to two or more drugs or foods); 7. Pregnant women; 8. Patients with mental illness, or poor compliance, who cannot cooperate with medication; 9. Other situations that the investigator considers inappropriate for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Foot and Ankle Ability Measure - Activities of Daily Living (FAAM-ADL); | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the Functional Activities of the Ankle and Ankle (FAAM-ADL) scores from baseline;The change in swelling rate from baseline;Time taken for pain to subside to mild pain or less;The proportion of subjects whose pain became mild or less;Changes in swelling values relative to baseline;Change in VAS score for activity-related pain from baseline;Change in resting pain VAS score from baseline; | — |
Countries
China
Contacts
Public ContactMa Xin
Shanghai Sixth People’s Hospital
Outcome results
None listed